Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: Multi - micronutrient supplement powder: The intervention group will receive standard care, Iron Folic Acid tablets (50 mg elemental iron and 500 mcg folic acid) and Multi-Micronutrient
Sponsors
Sri Madhusudan Sai Institute of Medical Sciences and Research
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women aged 18 to 35 years with 12 to 16 weeks of gestation and Hemoglobin above 8 g % and willing to give consent for the study.
Exclusion criteria
Exclusion criteria: 1. Those already started on IFA tablets/other multi-nutrient supplements 2. Pregnant women currently enrolled in another clinical trial. 3. Previously received transfusion or known case of anemia on treatment in the last 6 months prior to presentation. 4.Pregnant women with known: a. Pre-existing medical conditions like diabetes, HIV / AIDS, heart diseases, hypertension, asthma, renal failure, epilepsy, which are known to affect the outcome. b. Chronic gastrointestinal issues like Malabsorption syndromes, Inflammatory Bowel Disease, chronic pancreatitis, Crohnâ??s disease, ulcerative colitis, or chronic diarrhea. c. Hematological (blood) disorders like thalassemia, sickle cell anemia, or other hemoglobinopathies. d. Severe malnutrition or significant weight loss that could impact the study results. e. Allergies or hypersensitivity to any component of the multiple micronutrient powder. f. Severe mental health conditions that could affect their ability to comply with the study protocol. g. Active infectious diseases like tuberculosis or malaria. 5. Multiple pregnancy 6. Women who have had a severe illness or major surgery within 6 months before enrollment. 7. Women identified as having high-risk pregnancies due to factors like advanced maternal age or previous pregnancy complications. 8. Women with diagnosed deficiencies in nutrients not included in the micronutrient powder, which could confound results. 9. Women with precious pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin levels (g/dl) in pregnant womenTimepoint: Baseline, Follow up (after 3 months) and End line (at 9th month of gestation) | — |
Secondary
| Measure | Time frame |
|---|---|
| Birth weight (in grams) and length (in cms) of newbornsTimepoint: On the day of delivery | — |
Countries
India
Contacts
Public ContactDr Sandhya Gowthaman
Sri Madhusudan Sai Institute of Medical Sciences and Research
Outcome results
None listed